Literature DB >> 32127272

Viral Myocarditis-Incidence, Diagnosis and Management.

Megan Olejniczak1, Matthew Schwartz1, Elizabeth Webber1, Andrew Shaffer2, Tjorvi E Perry3.   

Abstract

Viral myocarditis has an incidence rate of 10 to 22 per 100,000 individuals. The presentation pattern of viral myocarditis can range from nonspecific symptoms of fatigue and shortness of breath to more aggressive symptoms that mimic acute coronary syndrome. After the initial acute phase presentation of viral myocarditis, the virus may be cleared, resulting in full clinical recovery; the viral infection may persist; or the viral infection may lead to a persistent autoimmune-mediated inflammatory process with continuing symptoms of heart failure. As a result of these 3 possibilities, the diagnosis, prognosis, and treatment of viral myocarditis can be extremely unpredictable and challenging for the clinician. Herein, the incidence, etiology, definition and classification, clinical manifestation, diagnosis, pathogenesis, prognosis, and treatment of viral myocarditis are reviewed, and how acute clinical care teams might differentiate between viral myocarditis and other acute cardiac conditions is discussed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fulminant viral myocarditis; mechanical circulatory support; parvovirus B19; viral myocarditis

Mesh:

Year:  2020        PMID: 32127272     DOI: 10.1053/j.jvca.2019.12.052

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  28 in total

1.  The effect of coenzyme Q10 plus trimetazidine on acute viral myocarditis treatment.

Authors:  Yong-Jun Yin; Si-Lu Zeng; Yan-Wei Li; Zhou Wu; Da-Jun Huang; Han-Zhang Tang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  Evaluation of the Efficacy and Safety of Chinese Herbal Injection Combined With Trimetazidine for Viral Myocarditis: A Network Meta-Analysis.

Authors:  Kerui Wu; Dingwei Deng; Binghui Yu; Ziyun Han; Lanlin Huang; Yaxing He; Xia Yan; Dawei Wang
Journal:  Front Pharmacol       Date:  2021-04-29       Impact factor: 5.988

3.  Long-term biventricular circulatory support with POLVAD-MEV paracorporeal pulsatile pumps. Single-centre experience.

Authors:  Tomasz K Urbanowicz; Hanna Baszyńska-Wachowiak; Anna Olasińska-Wiśniewska; Marcin Misterski; Sebastian Stefaniak; Marcin Ligowski; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-07-20

4.  Cardiovascular Consequences and Considerations of Coronavirus Infection - Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis.

Authors:  John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-04-09       Impact factor: 2.628

Review 5.  SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.

Authors:  Vincenzo Quagliariello; Annamaria Bonelli; Antonietta Caronna; Gabriele Conforti; Martina Iovine; Andreina Carbone; Massimiliano Berretta; Gerardo Botti; Nicola Maurea
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

6.  COVID-Associated Myocardial Injury: Crossing the Threshold for Mechanical Circulatory Support.

Authors:  Jonathan Ludmir; Shu Lu; Adam Dalia; Kenneth T Shelton
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-11-24       Impact factor: 2.628

7.  The benefits of Qigong exercise for symptoms of fatigue: A protocol for systematic review and meta-analysis.

Authors:  Rui Wang; Xueyan Huang; Yeqi Wu; Dai Sun
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

8.  A20 (TNFAIP3) alleviates viral myocarditis through ADAR1/miR-1a-3p-dependent regulation.

Authors:  Bin Li; Xing Xie
Journal:  BMC Cardiovasc Disord       Date:  2022-01-16       Impact factor: 2.298

9.  BEX1 is a critical determinant of viral myocarditis.

Authors:  Colton R Martens; Lisa E Dorn; Adam D Kenney; Shyam S Bansal; Jacob S Yount; Federica Accornero
Journal:  PLoS Pathog       Date:  2022-02-22       Impact factor: 6.823

Review 10.  The Role of Non-coding RNAs in Viral Myocarditis.

Authors:  Cong Zhang; Yan Xiong; Lijin Zeng; Zhihua Peng; Zhihao Liu; Hong Zhan; Zhen Yang
Journal:  Front Cell Infect Microbiol       Date:  2020-07-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.